High prevalence of gastrointestinal manifestations among Cytomegalovirus end-organ disease in the combination antiretroviral era

BACKGROUND: Cytomegalovirus (CMV) end-organ disease (EOD) continues to pose a significant risk to patients with advanced HIV disease despite decreased incidence with combination anti-retroviral therapy (ART) and lower mortality with effective anti-CMV therapy. Subclinical CMV shedding may also contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Caplan, Margaret R., Wilson, Eleanor M.P., Schechter, Melissa, Cai, Catherine W., Venner, Allison, Bishop, Rachel, Adelsberger, Joseph, Higgins, Jeanette, Roby, Gregg, Wang, Jing, Sheikh, Virginia, Sereti, Irini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446803/
https://www.ncbi.nlm.nih.gov/pubmed/34557308
http://dx.doi.org/10.1016/j.jve.2021.100052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446803/
https://www.ncbi.nlm.nih.gov/pubmed/34557308
http://dx.doi.org/10.1016/j.jve.2021.100052

Ejemplares similares